Neck Mass in a Young Adult: When to Observe, When to Operate
A 28-year-old woman presents with a 3.0 cm, nontender, mobile left level II neck mass first noticed 8 weeks ago. She reports no fever, night sweats, weight loss, dysphagia, hoarseness, or tobacco use. She was treated empirically with a 10-day course of amoxicillin-clavulanate 4 weeks ago with no change in size. Examination shows a firm, rubbery mass deep to the sternocleidomastoid, no other cervical lymphadenopathy, and a normal oropharynx, nasopharynx, larynx, and thyroid on flexible endoscopy. She has no prior tuberculosis exposure, no recent travel, and no pets. Fine-needle aspiration performed today at an outside clinic is reported as 'atypical lymphoid cells, nondiagnostic.'
1. What is your next diagnostic step, and why is the nondiagnostic FNA not reassuring here?
Read the worked answer
The nondiagnostic FNA does not exclude malignancy and does not exclude lymphoma; 'atypical lymphoid cells' is a category that mandates tissue architecture, which cytology cannot provide. The next step is excisional biopsy of the node (not repeat FNA, not observation).
Reasoning:
- In an adult with a persistent (>3 weeks) unilateral level II mass failing antibiotics, malignancy must be excluded. The differential is dominated by lymphoma (Hodgkin or non-Hodgkin) and metastatic squamous cell carcinoma, with branchial cleft cyst and mycobacterial infection lower on the list given the lack of inflammatory features.
- If lymphoma is suspected, core needle biopsy or excisional biopsy is preferred because flow cytometry and immunohistochemistry require viable cells and architecture; excisional biopsy remains the reference standard.
- If metastatic SCC is suspected, FNA with p16/HPV testing would be ideal, but a nondiagnostic aspirate in a young never-smoker still warrants tissue.
- Do not observe: a persistent cervical mass in an adult is malignant until proven otherwise.
2. The excisional biopsy shows Hodgkin lymphoma. How does the finding change your staging workup, and what determines treatment?
Read the worked answer
Hodgkin lymphoma is staged with PET-CT (functional staging is standard) plus bone marrow biopsy only if PET is equivocal or the patient has unexplained cytopenias; routine marrow biopsy is no longer mandatory when PET-CT is negative.
Key points:
- Staging is Ann Arbor with Lugano modifications; B symptoms (fever >38°C, drenching night sweats, >10% weight loss) and bulk (mediastinal mass >10 cm or >1/3 thoracic width) drive risk stratification.
- Treatment is stage- and risk-adapted: early-stage favorable disease may receive abbreviated chemotherapy plus involved-site radiation; advanced disease receives multiagent chemotherapy (e.g., ABVD or brentuximab-based regimens).
- Fertility counseling is essential in a 28-year-old before alkylator-containing or pelvic radiation; offer oocyte/embryo cryopreservation.
- Referral to medical oncology is the definitive next step; the otolaryngologist's role ends with diagnosis and airway surveillance.